Preclinical biotech developing RNA-based targeted therapies for cancer.
Industry: Health Care
First Day Return: +32.3%
Industry: Health Care
IPO Data | |
---|---|
IPO File Date | 02/26/2021 |
Offer Price | $4.00 |
Price Range $4.00 - $4.00 | |
Offer Shares (mm) | 6.3 |
Deal Size ($mm) | $25 |
Lock-Up Date | IPO Pro Only |
Street Research | IPO Pro Only |
IPO Data | |
---|---|
IPO Date | 07/08/2021 |
Offer Price | IPO Intelligence Only |
Price Range | IPO Intelligence Only |
Offer Shares (mm) | IPO Intelligence Only |
Deal Size ($mm) | $25 |
Lock-Up Date | IPO Intelligence Only |
Street Research | IPO Intelligence Only |
Underwriters |
---|
IPO Intelligence Only |
Company Data | |
---|---|
Headquarters | Boston, MA, United States |
Founded | 2016 |
Employees at IPO | 6 |
Website www.transcodetherapeutics.com |